---
title: "ARVN.US (ARVN.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ARVN.US/news.md"
symbol: "ARVN.US"
name: "ARVN.US"
parent: "https://longbridge.com/en/quote/ARVN.US.md"
datetime: "2026-05-20T22:44:33.301Z"
locales:
  - [en](https://longbridge.com/en/quote/ARVN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ARVN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ARVN.US/news.md)
---

# ARVN.US (ARVN.US) — Related News

### [Arvinas Employees Give Back During Company-wide Impact Day | ARVN Stock News](https://longbridge.com/en/news/286787555.md)
*2026-05-18T06:30:31.000Z*
> Arvinas Employees Give Back During Company-wide Impact Day | ARVN Stock News

### [Insider Selling: Arvinas (NASDAQ:ARVN) CAO Sells 1,919 Shares of Stock](https://longbridge.com/en/news/286321834.md)
*2026-05-13T21:42:59.000Z*
> Arvinas, Inc. (NASDAQ:ARVN) CAO David Loomis sold 1,919 shares at $9.94 each, totaling $19,074.86, to cover tax obligati

### [<![CDATA[Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu]]>](https://longbridge.com/en/news/286303707.md)
*2026-05-13T18:26:42.000Z*
> Rigel Pharmaceuticals has entered a global licensing agreement with Arvinas and Pfizer for Veppanu, a novel cancer thera

### [These Analysts Increase Their Forecasts On Arvinas After Q1 Results](https://longbridge.com/en/news/286300592.md)
*2026-05-13T17:54:35.000Z*
> Arvinas Inc (NASDAQ:ARVN) reported Q1 losses of 90 cents/share, missing estimates. The company also announced a global l

### [Arvinas Buy Rating Reiterated as Analyst Highlights Pipeline Optionality and VEPPANU Deal, Maintains $18 Price Target](https://longbridge.com/en/news/286287214.md)
*2026-05-13T15:05:20.000Z*
> H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Arvinas Holding Company, maintaining a price target of $1

### [<![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]>](https://longbridge.com/en/news/286273737.md)
*2026-05-13T13:21:12.000Z*
> Rigel Pharmaceuticals has entered an exclusive global license agreement with Arvinas and Pfizer to commercialize Veppanu

### [Arvinas Holding Company (ARVN) Receives a Buy from Wells Fargo](https://longbridge.com/en/news/286235748.md)
*2026-05-13T09:37:30.000Z*
> Wells Fargo analyst Derek Archila has maintained a Buy rating on Arvinas Holding Company (ARVN) with a price target of $

### [Pfizer PROTAC Licensing Deal With Rigel Adds Royalties To Valuation Story](https://longbridge.com/en/news/286183146.md)
*2026-05-13T02:11:24.000Z*
> Pfizer and Arvinas have licensed global rights for VEPPANU, the first FDA-approved oral PROTAC for advanced breast cance

### [](https://longbridge.com/en/news/286151833.md)
*2026-05-12T19:44:34.000Z*
> Rigel Pharma shares are trading higher. The company announced an exclusive, global license agreement with Arvinas and Pf